Saturday 24 October 2026 · Edition of the day

Current editionPast editions →

The Skeptic's Daily

The day's biggest stories, taken apart. For each one: what is actually established, what is only asserted, the questions worth asking — and a plausibility score for the central claim, given everything currently known.

Stories
4
Average plausibility
83%
How to read the score
It rates how well the core claim is evidenced — not how important the story is, nor whether it is good or bad news.
RegionAllGlobalAfricaNorth AmericaSouth AmericaAsia-PacificEuropeMiddle East
TopicAllPoliticsConflict & SecurityBusinessScienceHealth
01HealthEurope

MPs call for wider NHS access to weight-loss injections

BBC News reports criticism of plans to provide Mounjaro to 6% of eligible patients by 2028.

MPs are calling for more people to receive weight-loss injections through the NHS, according to BBC News. They describe current plans for 6% of eligible patients to receive Mounjaro by 2028 as unambitious.

What holds up

  • ✓The BBC item explicitly reports MPs’ call for expanded NHS access.
  • ✓It gives a specific coverage figure and deadline—6% of eligible patients by 2028—though no underlying plan is supplied.

What doesn't yet

  • ?The extract does not identify the MPs, define eligibility or provide the calculation behind the 6% figure.
  • ?Calling the plan unambitious is the MPs’ policy judgment; the item supplies no cost, capacity or government-response details.

Ask before you share

  • →Who counts as eligible, and what is the source of the 6% estimate?
  • →What funding and clinical capacity would wider access require?

Sources & original reporting

  1. [1]BBC News · Published 22 Oct 2026 · bbc.co.uk
02HealthAfrica

Kenya reports second Ebola death

Several outlets report the death of a 65-year-old woman related to Kenya’s first victim, while accounts differ on when that first patient died.

Kenya announced its second Ebola death, involving a 65-year-old woman who was a close relative of the first victim. DW reports that she developed symptoms while quarantined in Nairobi. Al Jazeera reports that authorities say there is no evidence of community spread.

What holds up

  • ✓BBC, Al Jazeera, France 24 and DW agree that Kenya reported a second Ebola death.
  • ✓BBC and DW agree on the woman’s age and close family relationship to the first victim.

What doesn't yet

  • ?DW places the first victim’s death last month; France 24 says earlier this month.
  • ?The claim of no evidence of community spread is an official assessment reported by Al Jazeera; the supplied items provide no surveillance data.

Ask before you share

  • →What testing and contact-tracing evidence supports the assessment of no community spread?
  • →Can authorities clarify the date of the first patient’s death?

Sources & original reporting

  1. [1]BBC News · Published 24 Oct 2026 · bbc.co.uk
  2. [2]Al Jazeera · Published 23 Oct 2026 · aljazeera.com
  3. [3]France 24 · Published 23 Oct 2026 · france24.com
  4. [4]DW · Published 23 Oct 2026 · dw.com
03HealthAfrica

Investigators examine possible link between Nigerian and Kenyan Ebola cases

Nigeria’s patient is identified as a Swiss diplomat’s wife, but the source of her infection remains unresolved.

BBC and the Guardian identify the woman with Ebola in Nigeria as the wife of a Swiss diplomat. NPR and DW report an investigation into whether patients in Nigeria and Kenya crossed paths, with DW identifying Uganda’s main airport as the possible location. Swiss officials say the woman’s husband is isolated without symptoms.

What holds up

  • ✓BBC and the Guardian both report the patient’s relationship to a Swiss diplomat, citing Swiss authorities.
  • ✓NPR and DW both report that investigators are examining a possible encounter between the Nigerian and Kenyan patients.

What doesn't yet

  • ?The Guardian reports a Swiss belief that infection occurred during travel in Uganda, but the source of infection remains uncertain.
  • ?DW refers to conflicting accounts without providing their details in the supplied summary; no transmission link is established.

Ask before you share

  • →What evidence would establish whether the patients met and whether transmission occurred?
  • →Is the proposed Uganda travel link supported by laboratory findings or only travel histories?

Sources & original reporting

  1. [1]BBC News · Published 23 Oct 2026 · bbc.co.uk
  2. [2]The Guardian · Published 23 Oct 2026 · theguardian.com
  3. [3]NPR · Published 23 Oct 2026 · npr.org
  4. [4]DW · Published 23 Oct 2026 · dw.com
04HealthGlobal

Personalized cancer vaccine trial reports reduced recurrence risk

Two outlets describe favorable trial results, but the excerpts omit the effect size and study methods.

The BBC reports that a personalized cancer vaccine reduced the risk of disease returning in a major trial. The Guardian describes a bespoke mRNA vaccine trial showing a significant reduction in the risk of melanoma recurrence or death.

What holds up

  • ✓Both outlets report favorable clinical trial findings for a personalized cancer vaccine.
  • ✓Both accounts describe reduced recurrence risk, with The Guardian specifying melanoma and an outcome including death.

What doesn't yet

  • ?Neither excerpt supplies trial size, comparator, follow-up duration, effect size or safety findings.
  • ?Descriptions of a turning point or foundational shift reflect researchers' interpretations, not proof of broad clinical benefit.

Ask before you share

  • →What were the absolute risk reduction, comparator and follow-up period?
  • →Which patients were studied, and what adverse effects occurred?

Sources & original reporting

  1. [1]BBC News · Published 23 Oct 2026 · bbc.co.uk
  2. [2]The Guardian · Published 23 Oct 2026 · theguardian.com